Nova Eye Medical

1985

Ellex Medical Lasers Limited founded in Adelaide, Australia

1992

Ellex Medical Lasers Limited commences contract manufacturing for a number of leading ophthalmic companies, including Alcon.

2006

Ellex Medical Lasers Limited launches direct market presence and relinquishes contract manufacturing arrangements.

2007

Ellex Medical Lasers Limited acquires Eye Cubed™ ultrasound business from US-based Innovative Imaging, Inc.

2014

Ellex Medical Lasers Limited acquires iTrack™ canaloplasty portfolio from US-based iScience Interventional, Inc.

2020

Ellex Medical Lasers Limited divests Ellex Laser & Ultrasound business and changes name to Nova Eye Medical Limited (ASX:EYE).

2020

Nova Eye Medical Limited acquires the Molteno3® Glaucoma Drainage Device business from Molteno Ophthalmic Limited.

With its sales headquarters based in Fremont, California, Nova Eye Medical is supported by a global network of more than 50 distribution partners. Manufacturing facilities are located in Fremont, California and Dunedin, New Zealand.

USA
Nova Eye, Inc
  • Headquarters USA
  • iTrack™ Manufacturing
  • iTrack™ R&D
  • iTrack™ Quality & Regulatory

At the heart of Nova Eye Medical is our iTrack™ MIGS procedure, known as ab-interno canaloplasty. An implant-free, tissue-sparing device, iTrack™ is helping to redefine the treatment of glaucoma in its early stages. iTrack™ can also be performed via an ab-externo approach to offer a highly effective, bleb-free alternative to traditional glaucoma surgery in the treatment of advanced glaucoma patients.

Acquired from world-leader Molteno Ophthalmic Ltd, the Molteno3® Glaucoma Drainage Device is a highly effective option for cases of severe and complex glaucoma and provides the added benefit of a simplified and faster surgical procedure.

Ellex is a registered trademark of Quantel Medical

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More